Virtus Fixed Income Advisers »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Virtus Fixed Income Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Virtus Fixed Income Advisers from 13F filings

Historical chart of Virtus Fixed Income Advisers investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Virtus Fixed Income Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Virtus Fixed Income Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $222k 152k 1.46

More positions owned by Virtus Fixed Income Advisers

Virtus Etf Tr Ii Newfleet Abs Mbs (VABS)
Virtus Etf Tr Ii Virtus Newfleet (VSHY)
Virtus Etf Tr Ii Seix Sr Ln Etf (SEIX)
Spdr Series Trust St Bloo High Etf (JNK)
Cable One Note 1.125% 3/1 (Principal)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Western Digital Corp Note 3.000%11/1 (Principal)
Virtus Etf Tr Ii Seix Aaa Privaat (PCLO)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
MKS Note 1.250% 6/0 (Principal)
Granite Constr Note 3.250% 6/1 (Principal)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
Snowflake Note 10/0 (Principal)
Boeing Dep Conv Pfd A (Principal) (BA.PA)
Snowflake Note 10/0 (Principal)

View all positions for Virtus Fixed Income Advisers

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Citadel Advisors
LMR Partners
Point72 Asset Management
Tenor Capital Management
Alberta Investment Management Corporation
Lombard Odier Asset Management
Millennium Management
Lazard Asset Management
Absolute Investment Advisers
Linden Advisors
Calamos Advisors
BlackRock
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1